UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000040446
Receipt No. R000046149
Scientific Title Interdisciplinary Centenarian and Semi-supercentenarian Study in Japan Part 1: the genetic study for healthy longevity
Date of disclosure of the study information 2020/05/26
Last modified on 2020/05/19 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Interdisciplinary Centenarian and Semi-supercentenarian Study in Japan Part 1: the genetic study for healthy longevity
Acronym Japan Centenarian and Semi-supercentenarian Study Part 1 (genetic study)
Scientific Title Interdisciplinary Centenarian and Semi-supercentenarian Study in Japan Part 1: the genetic study for healthy longevity
Scientific Title:Acronym Japan Centenarian and Semi-supercentenarian Study Part 1 (genetic study)
Region
Japan

Condition
Condition healthy longevity
Classification by specialty
Medicine in general Cardiology Endocrinology and Metabolism
Nephrology Neurology Geriatrics
Psychiatry Adult
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 The aim of this study is to identify genetic determinants of healthy longevity by using genomes from centenariansand semisupercentenarians. Our genetic analysis includes SNPs, exome, whole genome sequences, and epigenetics, transcriptomes, and telomere length.
Basic objectives2 Others
Basic objectives -Others The identification of protective genes for age-related diseases such as dementia and frailty.
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes all cause and cause-specific mortality
Key secondary outcomes incident disability, dementia, and chronic disease of aging

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
100 years-old <=
Age-upper limit
125 years-old >=
Gender Male and Female
Key inclusion criteria Centenarians: those who ages between 100 and 104 years old at enrollment
Semi-supercentenarians: those who ages 105 years and older at enrollment.
There is no upper limit for age at enrollment.
Key exclusion criteria Too frail or ill to participate
Target sample size 1700

Research contact person
Name of lead principal investigator
1st name Yasumichi
Middle name
Last name Arai
Organization Keio University School of Medicine
Division name Center for Supercentenarian Medical Research
Zip code 160-8582
Address 35, Shinanomachi, Shinjuku-ku, Tokyo, Japan
TEL 81352692468
Email yasumich@keio.jp

Public contact
Name of contact person
1st name Yasumichi
Middle name
Last name Arai
Organization Keio University School of Medicine
Division name Center for Supercentenarian Medical Research
Zip code 160-8582
Address 35, Shinanomachi, Shinjuku-ku, Tokyo, Japan
TEL 81352692468
Homepage URL http://www.keio-centenarian.com/
Email yasumich@keio.jp

Sponsor
Institute Keio University School of Medicine
Institute
Department

Funding Source
Organization Japan Agency for Medical Research and development (AMED)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Keio Global Research Institute, Keio University
Name of secondary funder(s) Ministry of Education, Culture, Sports, Science and Technology
Ministry of Health, Labor and Welfare
Ministry of Agriculture, Forestry, and Fisheries

IRB Contact (For public release)
Organization the Ethics committee of the Keio University School of Medicine
Address 35, Shinanomachi, Shinjuku-ku, Tokyo, Japan
Tel 81353633503
Email med-rinri-jimu@adst.keio.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 慶應義塾大学医学部(東京都)

Other administrative information
Date of disclosure of the study information
2020 Year 05 Month 26 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications http://www.keio-centenarian.com/
Number of participants that the trial has enrolled 930
Results
1. In 535 very old individuals and 930 centenarians, the frequency of APOE E4 allele was inversely correlated with age. Additionally, APOE E4 allele in centenarian men was significantly lower than that in centenarian women. 
2. In a single cell trascriptome analysis of peripheral blood mononuclear cells, derived from 7 supercentenarians and 5 younger controls, we identified identified a marked increase of cytotoxic CD4 T cells (CD4 cytotoxic T lymphocytes) as a signature of supercentenarians.
Results date posted
2020 Year 05 Month 18 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
2005 Year 08 Month 10 Day
Baseline Characteristics
Centenarians, semi-supercentenarians and their offspring and unrelated family living in Japan are enrolled in this study. 
Most of centenarians are female, and characterized by low prevalence of diabetes.
Participant flow
A toatal of 304 centenarians living in Tokyo (65 men, 239 women) were enrolled in the Tokyo Centenarian Study between 2000-2002.
Subsequently, more than 600 semi-supercentenarians living in the whole country in Japan has been recruited for the Japan Semi-supercentenarian Study (JSS) since 2002. The recruitment of JSS is still opening. 
Vital status of the study participants are followed annually by telephone of mail.
Adverse events
none
Outcome measures
1. all-cause and cause^specific mortality
2. Incidental disability, dementia, and age-related diseases.
Plan to share IPD Part of raw data are deposited in national database (NBDC).
IPD sharing Plan description https://humandbs.biosciencedbc.jp/en/hum0229-v1

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2000 Year 04 Month 01 Day
Date of IRB
2000 Year 04 Month 21 Day
Anticipated trial start date
2000 Year 07 Month 01 Day
Last follow-up date
2024 Year 12 Month 31 Day
Date of closure to data entry
2025 Year 03 Month 31 Day
Date trial data considered complete
2025 Year 03 Month 31 Day
Date analysis concluded
2026 Year 03 Month 31 Day

Other
Other related information This is a part of observational studies of centenarians and semi-supercentenarians living n Japan, which aims to identify genetic determinant of healthy longevity.

Management information
Registered date
2020 Year 05 Month 19 Day
Last modified on
2020 Year 05 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046149